Cargando…
Proteomic Profiles in Acute Respiratory Distress Syndrome Differentiates Survivors from Non-Survivors
Acute Respiratory Distress Syndrome (ARDS) continues to have a high mortality. Currently, there are no biomarkers that provide reliable prognostic information to guide clinical management or stratify risk among clinical trial participants. The objective of this study was to probe the bronchoalveolar...
Autores principales: | Bhargava, Maneesh, Becker, Trisha L., Viken, Kevin J., Jagtap, Pratik D., Dey, Sanjoy, Steinbach, Michael S., Wu, Baolin, Kumar, Vipin, Bitterman, Peter B., Ingbar, David H., Wendt, Christine H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188744/ https://www.ncbi.nlm.nih.gov/pubmed/25290099 http://dx.doi.org/10.1371/journal.pone.0109713 |
Ejemplares similares
-
Bronchoalveolar Lavage Fluid Protein Expression in Acute Respiratory Distress Syndrome Provides Insights into Pathways Activated in Subjects with Different Outcomes
por: Bhargava, Maneesh, et al.
Publicado: (2017) -
Application of clinical proteomics in acute respiratory distress syndrome
por: Bhargava, Maneesh, et al.
Publicado: (2014) -
Reversible platypnea-orthodeoxia in COVID-19 acute respiratory distress syndrome survivors
por: Tan, Geak Poh, et al.
Publicado: (2020) -
Hypoxia: An Unusual Cause with Specific Treatment
por: Berger, John P., et al.
Publicado: (2015) -
Changes of health-related quality of life in survivors of acute respiratory distress syndrome
por: Wehler, M, et al.
Publicado: (2003)